EE+ POEM Archive
Palivizumab prevents RSV and reduces later wheezing in preterm infants, but at high cost
Palivizumab prevents RSV and reduces later wheezing in preterm infants, but at high cost is a topic covered in the EE+ POEM Archive.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this entry is available only to subscribers.
Citation
Barry, Henry, et al., editors. "Palivizumab Prevents RSV and Reduces Later Wheezing in Preterm Infants, but at High Cost." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/427850/all/Palivizumab_prevents_RSV_and_reduces_later_wheezing_in_preterm_infants__but_at_high_cost.
Palivizumab prevents RSV and reduces later wheezing in preterm infants, but at high cost. In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/427850/all/Palivizumab_prevents_RSV_and_reduces_later_wheezing_in_preterm_infants__but_at_high_cost. Accessed September 21, 2021.
Palivizumab prevents RSV and reduces later wheezing in preterm infants, but at high cost. (2019). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/427850/all/Palivizumab_prevents_RSV_and_reduces_later_wheezing_in_preterm_infants__but_at_high_cost
Palivizumab Prevents RSV and Reduces Later Wheezing in Preterm Infants, but at High Cost [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2021 September 21]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/427850/all/Palivizumab_prevents_RSV_and_reduces_later_wheezing_in_preterm_infants__but_at_high_cost.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Palivizumab prevents RSV and reduces later wheezing in preterm infants, but at high cost
ID - 427850
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/427850/all/Palivizumab_prevents_RSV_and_reduces_later_wheezing_in_preterm_infants__but_at_high_cost
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
